These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12543699)

  • 1. Daily variations in ceftriaxone pharmacokinetics in rats.
    Rebuelto M; Ambros L; Rubio M
    Antimicrob Agents Chemother; 2003 Feb; 47(2):809-12. PubMed ID: 12543699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and dosage regimen of ceftriaxone in buffalo calves.
    Dardi MS; Sharma SK; Srivastava AK
    Vet Res Commun; 2004 May; 28(4):331-8. PubMed ID: 15222737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and dosage regimen of ceftriaxone in E. coli lipopolysaccharide induced fever in buffalo calves.
    Dardi MS; Sharma SK; Srivastava AK
    J Vet Sci; 2005 Jun; 6(2):147-50. PubMed ID: 15933435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients.
    Joynt GM; Lipman J; Gomersall CD; Young RJ; Wong EL; Gin T
    J Antimicrob Chemother; 2001 Apr; 47(4):421-9. PubMed ID: 11266414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Pharmacokinetic Profiles of Ceftriaxone Used Alone and Combined with Danhong Injection in Old Rats.
    Zhang Q; Guo J; Dai G; Li J; Zhu L; He S; Zong Y; Tang Z; Zhao B; Ju W; Duan J
    Eur J Drug Metab Pharmacokinet; 2019 Aug; 44(4):505-517. PubMed ID: 30511237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cationic analog of deoxycholate as an oral delivery carrier for ceftriaxone.
    Lee S; Kim SK; Lee DY; Park K; Kumar TS; Chae SY; Byun Y
    J Pharm Sci; 2005 Nov; 94(11):2541-8. PubMed ID: 16200559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics of ceftriaxone in intensive care].
    Bouget J; Garré M; Reyman JM; Guedes Y; Cartier F
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):706-10. PubMed ID: 3054752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the pharmacokinetics of ceftriaxone in neonates].
    Sunakawa K; Sato Y
    Jpn J Antibiot; 1988 Feb; 41(2):128-32. PubMed ID: 3373735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of a new, orally available ceftriaxone formulation in physical complexation with a cationic analogue of bile acid in rats.
    Lee S; Kim SK; Lee DY; Chae SY; Byun Y
    Antimicrob Agents Chemother; 2006 May; 50(5):1869-71. PubMed ID: 16641464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of ceftriaxone in patients with typhoid fever.
    Acharya G; Crevoisier C; Butler T; Ho M; Tiwari M; Stoeckel K; Bradley CA
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2415-8. PubMed ID: 7840580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition kinetics and dosage regimen of ceftriaxone in crossbred calves (short communication).
    Johal B; Srivastava AK
    Acta Vet Hung; 1999; 47(2):243-8. PubMed ID: 10344084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of liposome-encapsulated ciprofloxacin compared with ciprofloxacin and ceftriaxone in a rat model of pneumococcal pneumonia.
    Ellbogen MH; Olsen KM; Gentry-Nielsen MJ; Preheim LC
    J Antimicrob Chemother; 2003 Jan; 51(1):83-91. PubMed ID: 12493791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of ceftriaxone in liver-transplant recipients.
    Toth A; Abdallah HY; Venkataramanan R; Teperman L; Halsf G; Rabinovitch M; Burckart GJ; Starzl TE
    J Clin Pharmacol; 1991 Aug; 31(8):722-8. PubMed ID: 1880231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are Standard Dosing Regimens of Ceftriaxone Adapted for Critically Ill Patients with Augmented Creatinine Clearance?
    Ollivier J; Carrié C; d'Houdain N; Djabarouti S; Petit L; Xuereb F; Legeron R; Biais M; Breilh D
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30602511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the relationship between serum and milk residue disposition of ceftriaxone in lactating ewes.
    Goudah A; Shin HC; Shim JH; Abd El-Aty AM
    J Vet Pharmacol Ther; 2006 Aug; 29(4):307-12. PubMed ID: 16846468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of ceftriaxone administered by the intravenous, intramuscular or subcutaneous routes to dogs.
    Rebuelto M; Albarellos G; Ambros L; Kreil V; Montoya L; Bonafine R; Otero P; Hallu R
    J Vet Pharmacol Ther; 2002 Feb; 25(1):73-6. PubMed ID: 11874531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total and unbound ceftriaxone pharmacokinetics in critically ill Australian Indigenous patients with severe sepsis.
    Tsai D; Stewart P; Goud R; Gourley S; Hewagama S; Krishnaswamy S; Wallis SC; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2016 Dec; 48(6):748-752. PubMed ID: 27838278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of ceftriaxone after intravenous, intramuscular and subcutaneous administration to domestic cats.
    Albarellos GA; Kreil VE; Landoni MF
    J Vet Pharmacol Ther; 2007 Aug; 30(4):345-52. PubMed ID: 17610408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in ceftriaxone pharmacokinetics/pharmacodynamics during the early phase of sepsis: a prospective, experimental study in the rat.
    Selmi V; Loriga B; Vitali L; Carlucci M; Di Filippo A; Carta G; Sgambati E; Tofani L; De Gaudio AR; Novelli A; Adembri C
    J Transl Med; 2016 Nov; 14(1):316. PubMed ID: 27846855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of ceftriaxone in freshwater crocodiles (Crocodylus siamensis) after intramuscular administration at two dosages.
    Poapolathep S; Giorgi M; Chaiyabutr N; Klangkaew N; Phaochoosak N; Wongwaipairote T; Poapolathep A
    J Vet Pharmacol Ther; 2020 Mar; 43(2):141-146. PubMed ID: 31353505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.